- Home
- CMRX vs ARRY Comparison
CMRX vs ARRY Comparison
Compare CMRX & ARRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMRX
- ARRY
- Stock Information
- Founded
- CMRX 2000
- ARRY 1989
- Country
- CMRX United States
- ARRY United States
- Employees
- CMRX N/A
- ARRY N/A
- Industry
- CMRX Biotechnology: Pharmaceutical Preparations
- ARRY Semiconductors
- Sector
- CMRX Health Care
- ARRY Technology
- Exchange
- CMRX Nasdaq
- ARRY Nasdaq
- Market Cap
- CMRX 797.3M
- ARRY 649.7M
- IPO Year
- CMRX 2013
- ARRY 2020
- Fundamental
- Price
- CMRX $8.54
- ARRY $4.33
- Analyst Decision
- CMRX Hold
- ARRY Buy
- Analyst Count
- CMRX 4
- ARRY 21
- Target Price
- CMRX $8.51
- ARRY $9.82
- AVG Volume (30 Days)
- CMRX 2.0M
- ARRY 4.2M
- Earning Date
- CMRX 04-30-2025
- ARRY 05-06-2025
- Dividend Yield
- CMRX N/A
- ARRY N/A
- EPS Growth
- CMRX N/A
- ARRY N/A
- EPS
- CMRX N/A
- ARRY N/A
- Revenue
- CMRX $212,000.00
- ARRY $915,807,000.00
- Revenue This Year
- CMRX $2,416.04
- ARRY $21.97
- Revenue Next Year
- CMRX $923.92
- ARRY $12.71
- P/E Ratio
- CMRX N/A
- ARRY N/A
- Revenue Growth
- CMRX N/A
- ARRY N/A
- 52 Week Low
- CMRX $0.75
- ARRY $3.76
- 52 Week High
- CMRX $8.55
- ARRY $14.85
- Technical
- Relative Strength Index (RSI)
- CMRX 80.86
- ARRY 39.16
- Support Level
- CMRX $8.50
- ARRY $3.98
- Resistance Level
- CMRX $8.55
- ARRY $4.32
- Average True Range (ATR)
- CMRX 0.02
- ARRY 0.38
- MACD
- CMRX -0.12
- ARRY 0.01
- Stochastic Oscillator
- CMRX 88.89
- ARRY 46.72
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
About ARRY Array Technologies Inc.
Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.